Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D D Ross

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
The Journal of Biological Chemistry|November 25, 1975
Effects of urinary proteins from certain leukemics upon macromolecular synthesis and enzyme levels in bone marrow culturesD D Ross, D P Groth, J M Kinkade
Journal of Palliative Medicine|January 19, 2002
Institutionalization of a palliative and end-of-life care educational program in a medical school curriculumD D Ross, H C Fraser, J S Kutner
Blood|July 1, 1986
Effects of verapamil on in vitro intracellular accumulation and retention of daunorubicin in blast cells from patients with acute nonlymphocytic leukemiaD D Ross, C C Joneckis, C A Schiffer
Anticancer Research|June 16, 1999
Combinations of P-glycoprotein blockers, verapamil, PSC833, and cremophor act differently on the multidrug resistance associated protein (MRP) and on P-glycoprotein (Pgp)A Aszalos, K Thompson, J J Yin, et al.
International Journal of Cancer|September 4, 1995
Characterization of a 95 kilodalton membrane glycoprotein associated with multi-drug resistanceL A Doyle, Y Gao, W Yang, et al.
Experimental Hematology|August 1, 1980
Diurnal variation of circulating human myeloid progenitor cellsD D Ross, A Pollak, S A Akman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Mechanistic implications of alterations in HL-60 cell nascent DNA after exposure to 1-beta-D-arabinofuranosylcytosineD D Ross, D P Cuddy, N Cohen, et al.
Blood|July 13, 2000
Expression of breast cancer resistance protein in blast cells from patients with acute leukemiaD D Ross, J E Karp, T T Chen, et al.
Cancer Research|February 1, 1988
Bromodeoxyuridine enhancement of 1-beta-D-arabinofuranosylcytosine metabolic activation and toxicity in HL-60 leukemic cellsD D Ross, C C Joneckis, T H Song, et al.
Biochimica Et Biophysica Acta|September 22, 2001
Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) geneK J Bailey-Dell, B Hassel, L A Doyle, et al.
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
The Journal of Biological Chemistry|November 25, 1975
Effects of urinary proteins from certain leukemics upon macromolecular synthesis and enzyme levels in bone marrow culturesD D Ross, D P Groth, J M Kinkade
Journal of Palliative Medicine|January 19, 2002
Institutionalization of a palliative and end-of-life care educational program in a medical school curriculumD D Ross, H C Fraser, J S Kutner
Blood|July 1, 1986
Effects of verapamil on in vitro intracellular accumulation and retention of daunorubicin in blast cells from patients with acute nonlymphocytic leukemiaD D Ross, C C Joneckis, C A Schiffer
Anticancer Research|June 16, 1999
Combinations of P-glycoprotein blockers, verapamil, PSC833, and cremophor act differently on the multidrug resistance associated protein (MRP) and on P-glycoprotein (Pgp)A Aszalos, K Thompson, J J Yin, et al.
International Journal of Cancer|September 4, 1995
Characterization of a 95 kilodalton membrane glycoprotein associated with multi-drug resistanceL A Doyle, Y Gao, W Yang, et al.
Experimental Hematology|August 1, 1980
Diurnal variation of circulating human myeloid progenitor cellsD D Ross, A Pollak, S A Akman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Mechanistic implications of alterations in HL-60 cell nascent DNA after exposure to 1-beta-D-arabinofuranosylcytosineD D Ross, D P Cuddy, N Cohen, et al.
Blood|July 13, 2000
Expression of breast cancer resistance protein in blast cells from patients with acute leukemiaD D Ross, J E Karp, T T Chen, et al.
Cancer Research|February 1, 1988
Bromodeoxyuridine enhancement of 1-beta-D-arabinofuranosylcytosine metabolic activation and toxicity in HL-60 leukemic cellsD D Ross, C C Joneckis, T H Song, et al.
Biochimica Et Biophysica Acta|September 22, 2001
Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) geneK J Bailey-Dell, B Hassel, L A Doyle, et al.
Pageof 7